SLC2A1 and Dravet syndrome: Our model also failed to show any ameliorative effects of injecting metabolites at points of anaplerotic entry into the TCA cycle, a result which supports recent clinical findings that triheptanoin is ineffective in reducing seizures in patients with GLUT1-DS who are not already on a KD diet [35].